Insider · CIK 0001664569

Afdhal Nezam H.

Reports to the SEC for 1 company · HOPKINTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001664569

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-01-24	F-star Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2018-01-16	F-star Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2017-02-09	F-star Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2016-11-23	F-star Therapeutics, Inc.Warrant (right to buy)A Award	Chief Medical Officer	AAward	+13.2K sh	—	—	13,150
2016-11-23	F-star Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+13.2K sh	$9.12	+$120K	53,300
2016-09-09	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+2,400 sh	$12.50	+$30K	40,150
2016-08-24	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+1,550 sh	$11.90	+$18.4K	37,300
2016-08-24	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+100 sh	$11.99	+$1,199	37,400
2016-08-24	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+350 sh	$12.00	+$4,200	37,750
2016-08-16	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+100 sh	$11.49	+$1,149	35,750
2016-08-15	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+1,800 sh	$11.43	+$20.6K	35,650
2016-08-12	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+1,000 sh	$11.32	+$11.3K	33,850
2016-08-12	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+2,600 sh	$11.33	+$29.4K	33,850
2016-08-10	F-star Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+1,600 sh	$10.81	+$17.3K	32,850
2016-05-19	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+5,000 sh	—	—	5,000

Recent filings

Accepted (ET)
Jan 254
Afdhal Nezam H.0001209191-19-005449
SEC(opens sec.gov)
Jan 174
Afdhal Nezam H.0001209191-18-003915
SEC(opens sec.gov)
Feb 104
Spring Bank Pharmaceuticals, Inc.0001209191-17-009529
SEC(opens sec.gov)
Nov 234
Spring Bank Pharmaceuticals, Inc.0000899243-16-034297
SEC(opens sec.gov)
Sep 124
Spring Bank Pharmaceuticals, Inc.0001209191-16-140920
SEC(opens sec.gov)
Aug 244
Spring Bank Pharmaceuticals, Inc.0001209191-16-138557
SEC(opens sec.gov)
Aug 164/A
Spring Bank Pharmaceuticals, Inc.0001209191-16-137309
SEC(opens sec.gov)
Aug 164
Spring Bank Pharmaceuticals, Inc.0001209191-16-137269
SEC(opens sec.gov)
Aug 154
Spring Bank Pharmaceuticals, Inc.0001209191-16-137099
SEC(opens sec.gov)
May 204
Spring Bank Pharmaceuticals, Inc.0000899243-16-020579
SEC(opens sec.gov)

Companies

F-star Therapeutics, Inc.Chief Medical Officer

Address

C/O SPRING BANK PHARMACEUTICALS, INC. 86 SOUTH STREET

HOPKINTON, MA, 01748